http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113827715-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_394459bca5b2c04619873c2b15679c7f |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-295 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-145 |
| filingDate | 2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6adb14b59102f7731c2677c0492ec95b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79682d2b63c30e1adc191bb7b43426c4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab651aae0706565d69af5fd6b840aeae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d584cebee3d09dbdb073095fa483ff2 |
| publicationDate | 2021-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113827715-A |
| titleOfInvention | Vaccine composition for resisting H7 subtype and H5 subtype avian influenza viruses, and preparation method and application thereof |
| abstract | The invention relates to a vaccine composition for resisting H7 subtype and H5 subtype avian influenza viruses, which comprises immunization amount of H7 subtype avian influenza virus-like particle antigen, immunization amount of H5 subtype avian influenza virus-like particle antigen and a pharmaceutically acceptable carrier, wherein the H7 subtype avian influenza virus-like particle antigen is assembled by H7 subtype avian influenza virus HA, NA and M1 antigen proteins, the H7 subtype avian influenza virus HA antigen protein is shown as Seq ID No.1, the H7 subtype avian influenza virus NA antigen protein is shown as Seq ID No.2, and the H7 subtype avian influenza virus M1 antigen protein is shown as Seq ID No. 3. The vaccine composition can protect the existing H7 subtype epidemic strains, has equivalent or better effect compared with the inactivated vaccine with the same antigen content, and generates synergistic interaction among the components of the vaccine composition, thereby further ensuring the immune effect. |
| priorityDate | 2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1030.